Mersana Therapeutics MRSN reported its Q1 earnings results on Monday, May 9, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Mersana Therapeutics missed estimated earnings by 84.37%, reporting an EPS of $-0.59 versus an estimate of $-0.32.
Revenue was up $2.02 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 6.61% increase in the share price the next day.
To track all earnings releases for Mersana Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.